Drug Trial Radar · NCT07419334
Study of ALK-001 on the Progression of Stargardt Disease
Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Jun 3, 2026
Primary completion
Oct 2029
Study completion Dec 2030
Sponsor
- Lead sponsor
- Alkeus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 8 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (STGD)
Conditions
- Stargardt Disease
Interventions
ALK-001Drug
Daily oral administration for 24 months
PlaceboDrug
Daily oral administration for 24 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized growth rate of retinal atrophic lesions measured by Fundus AutofluorescenceTime frame: Month 6 to Month 24
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona · Recruiting
University of Colorado SOM, Sue-Anschutz-Rodgers Eye Center
Aurora, Colorado · Recruiting
Vitreo Retinal Associates
Gainesville, Florida · Recruiting
Tufts Medical Center - New England Eye Center
Boston, Massachusetts · Not yet recruiting
Foundation for Vision Research
Grand Rapids, Michigan · Recruiting
Ohio State Havener Eye Institute
Columbus, Ohio · Recruiting
Erie Retina Research
Erie, Pennsylvania · Recruiting
Mid Atlantic Retina
Philadelphia, Pennsylvania · Not yet recruiting
UPMC Vision Institute
Pittsburgh, Pennsylvania · Recruiting
Retina Foundation of the Southwest
Dallas, Texas · Recruiting
Star Retina
Fort Worth, Texas · Recruiting
Medical Center Ophthalmology Associates
San Antonio, Texas · Recruiting
The Retina Group of Washington
Fairfax, Virginia · Recruiting
Wagner Kapoor Research Institute
Norfolk, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.